Safety Study of BLZ-100 in Adult Subjects With Glioma Undergoing Surgery
NCT02234297
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class
Conditions
Glioma
Interventions
DRUG:
BLZ-100
Sponsor
Blaze Bioscience Inc.